Platelets GP-IIB-IIA receptor inhibitors in ischemic patients;Gli inibitori dei recettori glicoproteici IIB-IIIA delle piastrine nei pazienti con cardiopatia ischemica

Clinica Terapeutica

Volumn 151, Issue 4, 2000, Pages 301-306

  Patti, G ^a   Fossati, C ^a   Manzoli, A ^a   D'Ambrosio, A ^a   Abbate, A ^a   Montesanti, R ^a   Di Sciascio, G ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

Acute myocardial infarction; Coronary angioplasty; IIb IIIa glycoprotein inhibitors; Ischemic heart disease; Platelets; Unstable coronary syndromes

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; LAMIFIBAN; ORBOFIBAN; PLACEBO; SIBRAFIBAN; TICLOPIDINE; TIROFIBAN; TROPONIN; XEMILOFIBAN;

BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; DRUG MECHANISM; DRUG METABOLISM; HEART DEATH; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PHARMACODYNAMICS; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; REVIEW;

ACETATES; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; DIABETES COMPLICATIONS; FIBRINOLYTIC AGENTS; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MULTICENTER STUDIES; MYOCARDIAL ISCHEMIA; PEPTIDES; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RANDOMIZED CONTROLLED TRIALS; STENTS; SURVIVAL ANALYSIS; SYNDROME; TREATMENT OUTCOME; TROPONIN; TYROSINE;

EID: 0033782161     PISSN: 00099074     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty
2. Platelet glycoprotein IIb/IIIa blockade with abciximab with low-dose heparin during percutaneous coronary revascularization
3. Randomized placebo-controlled and balloon-angioplasty controlled trial to assess safety of coronary stenting with use of platelet glycoprotein IIb/IIIa blockade
4. A randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction
5. Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty
6. Randomized placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT II
7. Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention
8. Enhanced survival with platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: 1 year outcomes and health care economic implications from a multicenter, randomized trial
9. Complementary clinical benefits of coronary artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors
10. Reduction of clinical restenosis following coronary intervention with early administration of platelet IIb/IIIa integrin blocking antibody
11. Acute platelet inhibitors with abciximab does not reduce in-stent restenosis (ERASER Study)
12. Randomized placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: The CAPTURE study
13. A comparison of aspirin plus tirofiban with aspirin plus beparin for unstable angina
14. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q wave myocardial infarction
15. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes
16. International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin or both in unstable angina
17. Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction. Observations from the TIMI 14 trial
18. Abciximab in the treatment of acute myocardial infarction eligible, for primary percutaneous transluminal coronary angioplasty: Results of the Glycoprotein Receptor Antagonist Patency evaluation (GRAPE) pilot study
19. Combination therapy for acute myocardial infarction
20. Safety of abciximab retreatment - Final clinical report of the ReoPro Readministration Registry
21. Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: A randomised trial
22. Long-term treatment with a platelet glycoprotein-receptor antagonist after percutaneous coronary revascularization
23. Improved cardiac outcomes in diabetic unstable angina/non-Q wave myocardial infarction patients treated with tirofiban and heparin
24. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels for the c7E3 FAB Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE)